BRAINCELL
BRAINCELL, licence 80093513: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- CELLFIRE (5005122 Ontario Limited)
- NPN or DIN-HM
- 80093513
- Status
- Active licence
- Licence date
- 24 July 2019
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide 1H-pyrrolo(2,3-f)quinoline-2,7,9-tricarboxylique, 4,5-dihydro-4,5-dioxo- Source : Pyrroloquinoline quinone | 3.3 mg | Not calculated |
| Sel interne de (2R)-2-(Acétyloxy)-3-carboxy-N,N,N-triméthyl-1-propanaminium Source : Acétyl-L-Carnitine | 166.7 mg | Not calculated |
| 2-(diméthylamino)éthanol Source : Deanol | 166.7 mg | Not calculated |
| Cytidine 5'-diphosphocholine Source : Citicoline | 83.3 mg | Not calculated |
| Phosphatidylsérine Source : Lécithine de soja enrichie en phosphatidylsérine | 66.7 mg | Not calculated |
| (3R,3'R,6'R)-bêta,epsilon-carotène-3,3'-diol Source : Lutéine(USP) | 6.7 mg | Not calculated |
| [5R-(5alpha, 9beta, 11E)]-5-amino-11-éthylidène-5 ,6,9,10-tétrahydro-7-méthyl-5 ,9-méthane-cycloocta [b] pyridine-2 (1H)-one Source : Huperzine A | 33.3 mcg | Not calculated |
| [5R-(5alpha, 9beta, 11E)]-5-amino-11-éthylidène-5 ,6,9,10-tétrahydro-7-méthyl-5 ,9-méthane-cycloocta [b] pyridine-2 (1H)-one Source : Huperzia serrata - plante entière | 33.3 mcg | Not calculated |
| L-Tyrosine Source : N-acétyltyrosine | 166.7 mg | Not calculated |
| Sceletium tortuosum Source : Feuille et tige Extraction ratio : 2:1 Dry plant equivalent : 16.6 mg Potency : 0.4 % Total alkaloids | 8.3 mg | Not calculated |
| Vinpocétine Source : Vinpocetine | 1.7 mg | Not calculated |
Non-medicinal ingredients
Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe masculin | minimum: 18.0 Année(s) ; maximum: 40.0 Année(s) | 3.0 Capsule | 1.0 Jour(s) |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of/An antioxidant for the maintenance of good health/eye health. Source of/An antioxidant that helps fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Helps support cognitive function in adults. Helps to support cognitive performance in a healthy aging population.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80093513
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.